Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
Current article presents commentary on official inclusion of cardiovascular prophylaxis in indications for Diabeton MR therapy. The paper features extensive review of data from ADVANCE (Action in Diabetes and Vascular Disease: PretarAx and DiamicroN Modified Release Controlled Evaluation) trial and...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7350b0a553df402f90fc530ba2fec613 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|